by Megan Durham | Mar 24, 2026 | CT Simulation, Radiation Therapy
CT simulation, also called CT sim or CT simulator radiotherapy, is an important part of radiation therapy. This information-gathering stage ensures that the therapy hits the correct treatment targets and helps us come up with the most effective treatment plan for each...
by Sarah Mayes | Dec 11, 2024 | Patient Resources, Prostate Cancer, Radiation Therapy
If you or a loved one have recently been diagnosed with prostate cancer, you will likely have questions about treatment and what to expect. You may also want to know more about the diagnosis process. Prostate cancer diagnosis and treatment usually incorporate...
by Megan Durham | Aug 14, 2024 | IMRT, Prostate Cancer, Radiation Therapy
One of the most common questions we receive is how long a single radiation treatment will take. We completely understand—getting a cancer diagnosis and figuring out how that impacts your life can be very stressful. Here, we’ll provide some answers that we hope will...
by Megan Durham | Jul 10, 2024 | Prostate Cancer, Radiation Therapy
Cancer fatigue, also known as cancer-related fatigue, or CRF, is an ongoing feeling of tiredness and exhaustion following treatment for a cancer diagnosis. Whether a patient’s cancer treatment includes surgery, chemotherapy, radiation, or a combination of the three,...
by Sarah Mayes | May 29, 2024 | CBCT, CT Simulation, IGRT, IMRT, Radiation Therapy
Most prostate cancers are treated by two different types of radiation therapy: external beam radiation therapy (EBRT) and brachytherapy (or internal radiation). Both EBRT and brachytherapy use targeted radiation to detect and kill cancer cells, however each therapy...
by Sarah Mayes | May 22, 2024 | IGRT, IMRT, Prostate Cancer
Prostate cancer is the most common type of cancer among people with prostates, except for skin cancer. In 2023, it was estimated that over 288,000 people in the United States would be diagnosed with prostate cancer. This type of cancer is typically slow-growing, but...
